This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Myriad Genetics, Inc., University of Utah Research Foundation, The United States of America as Represented by the Department of Health. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 123 
4 out of 1,687 
2 out of 1,217 
Years Active: 1998-2000
Title: The Impact of P Andrew Futreal on Cancer Genetics
Introduction: P Andrew Futreal is a prominent inventor residing in Durham, NC, known for his significant contributions to the field of human genetics. With a robust portfolio of four patents, his work predominantly focuses on understanding and diagnosing breast and ovarian cancer susceptibility.
Latest Patents: Among his latest innovations, Futreal has developed patents related to the 17q-linked and 170-linked breast and ovarian cancer susceptibility gene, specifically the BRCA1 gene. The inventions provide crucial methods and materials for isolating and detecting the BRCA1 gene and its mutant alleles, which are associated with increased cancer risk. His patents explore the potential of germline mutations for diagnosing predispositions to breast and ovarian cancer, as well as the implications of somatic mutations in other human cancers. Furthermore, his inventions extend to therapeutic methods, including gene therapy and drug screening pathways for effective cancer treatment.
Career Highlights: P Andrew Futreal has had a distinguished career that has seen him associated with notable institutions. His work with the University of Utah Research Foundation and Myriad Genetics, Inc. has played a vital role in his research and development efforts, bringing groundbreaking innovations to light in the medical field.
Collaborations: Throughout his career, Futreal has collaborated with esteemed colleagues, including Mark H. Skolnick and David E. Goldgar. These partnerships have fostered a productive research environment, leading to advancements in genetic understanding and cancer therapeutics.
Conclusion: P Andrew Futreal's contributions to cancer genetics are invaluable, and his patented inventions have the potential to revolutionize the diagnosis and treatment of breast and ovarian cancer. His dedication to research and collaboration continues to strengthen the field of human genetics, providing hope for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile